LV Only MPP With SyncAV

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.

Also called NCT03567096

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 101 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03567096
Other papers using this trial's data
  • Left Ventricular and Biventricular Multipoint Pacing With Dynamic Atrioventricular Delays: 6-Month Cardiac Resynchronization Therapy Response Journal of cardiovascular electrophysiology, 2026-04 DOI, PubMed 41755392

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada, France, Italy, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03567096. Randomized; single masking; primary purpose treatment. Start 2018-10-09 (actual); primary completion 2023-02-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
LV Only MPP With SyncAV
Condition
Heart Failure
Condition
Left Bundle-Branch Block
Intervention (Device)
BiV pacing with MPP and SyncAV
Intervention (Device)
LV only pacing with MPP and SyncAV
Lead sponsor
Abbott Medical Devices (class: industry)
Collaborator
Abbott (class: industry)

Record details

Record id
cardio:ct-nct03567096
Content hash
7a1159ffb3e883ea1b3957b6704faaa374eefa46fa81d1f331e549cb94ec7cff